Core Viewpoint - Ardent Health, Inc. is under investigation for potential violations of federal securities laws due to improper accounting practices related to accounts receivable and professional liability reserves [2][4]. Financial Performance - On November 12, 2025, Ardent reported a $43 million decrease in revenue for Q3 2025 after conducting "hindsight evaluations of historical collection trends" [5]. - The company also increased its professional liability reserves by $54 million due to adverse claim developments from 2019 to 2022 and broader industry trends [5]. - Following these disclosures, Ardent's stock price dropped over 33% during trading on November 13, 2025 [5]. Legal Context - Bleichmar Fonti & Auld LLP is leading the investigation and encourages investors who lost money to contact them for potential legal options [2][6]. - The firm operates on a contingency fee basis, meaning shareholders are not responsible for court costs or litigation expenses [6].
ARDT NOTIFICATION: BFA Law Notifies Ardent Health, Inc. Investors of the Pending Class Action Investigation and to Contact the Firm if You Lost Money